Atomoxetine caps: Supply issue resolved

Arrotex Pharmaceuticals advise that 60 mg, 80 mg, and 100 mg presentations are back in stock with a registered product with new packaging and pharmacodes. The registered 10 mg is still out of stock.

Update: 10 August 2022

Supply issue resolved. All presentations are back in stock with the contracted product. 

10 mg presentation in stock

10 mg APO-Atomoxetine (2638517) is in stock.

Check the Schedule listing for atomoxetine(external link) 

To cover the supply outage, we have previously listed Eli Lily's Strattera brand in 10 mg. We will delist this product in due course to allow time for stock to be used up. 

  • 10 mg cap | Pharmacode 2181568 | 107.03 / 28 Pack

You can check all items to be delisted(external link) on our website


New pharmacodes for 60, 80 and 100 mg presentations

Arrotex have advised their brand of Atomoxetine 60mg, 80 mg and 100mg has been restored. However, this product is now supplied under the APO-Atomoxetine brand with new packaging and Pharmacodes. 

There is no change to the actual product.

New pharmacodes:

  • 60 mg APO-Atomoxetine – 2638525
  • 80 mg APO-Atomoxetine – 2638533
  • 100 mg APO-Atomoxetine – 2638541 

Arrotex will phase in the APO-Brand for the remaining strengths as existing stock is exhausted

Alternative listings

We have previously listed an Australian version of Arrotex's atomoxetine product. Note these are now listed as Apo-Atomoxetine s29, they are not Medsafe approved.

  • 10 mg cap | Pharmacode 2632497 | $18.41 / 28 pack
  • 60 mg cap | Pharmacode 2636050 $46.51 / 28 Pack
  • 80 mg cap | Pharmacode 2632500 | $56.45 / 28 pack
  • 100 mg cap | Pharmacode 2632519 | $58.48 / 28 pack

Other presentations of atomoxetine (18 mg, 25 mg, and 40 mg) are not affected by this supply issue. 

Prescribing and supplying a medicine under section 29

Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – e.g., doctors.  

Prescriber and pharmacist requirements for section 29 medicines – Medsafe website(external link)

What patients need to know about section 29 medicines – Health Navigator website(external link)

Who to contact

If you take atomoxetine, talk to your pharmacist or the person who prescribed it to you. They know you best. Pharmac cannot give clinical advice on any individual person.

If you have questions about supply, contact Arrotex or your wholesaler. 

If you have questions about funding for atomoxetine, email us on